Clinical Trial Update: Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial evaluating ascending doses of crofelemer powder for oral solution in Microvillus inclusion disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microvillus Inclusion Disease

Drugs mentioned

• Mytesi (crofelemer)

Snippet

Sponsor: Napo Pharmaceuticals, Inc. | Conditions: Microvillus Inclusion Disease, Congenital Disorders | Phase 2 | Status: RECRUITING